Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $354M | $270M | $262M | $271M | $264M | $291M | $316M | $339M | $304M | $292M |
| Revenue growth | — | -23.8% | -3.0% | 3.4% | -2.4% | 10.2% | 8.7% | 7.1% | -10.3% | -3.8% |
| Gross profit | $174M | $144M | $144M | $156M | $150M | $157M | $166M | $174M | $155M | $158M |
| Gross margin | 49.3% | 53.4% | 55.0% | 57.6% | 56.9% | 53.9% | 52.4% | 51.4% | 50.9% | 53.9% |
| Operating income | $1.02M | -$11.2M | -$14.2M | -$9.40M | -$167M | -$35.3M | -$28.5M | -$51.2M | -$192M | -$40.0M |
| Operating margin | 0.3% | -4.1% | -5.4% | -3.5% | -63.3% | -12.1% | -9.0% | -15.1% | -63.3% | -13.7% |
| Net income | -$43.6M | $5.01M | $16.3M | $61.3M | -$167M | -$31.5M | -$26.5M | -$52.4M | -$184M | -$34.0M |
| Net margin | -12.3% | 1.9% | 6.2% | 22.7% | -63.1% | -10.8% | -8.4% | -15.5% | -60.7% | -11.6% |
| EPS (diluted) | -$1.21 | $0.14 | $0.44 | $1.64 | -$4.39 | -$0.82 | -$0.68 | -$1.33 | -$4.59 | -$0.83 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $45.2M | $55.7M | $41.3M | $37.4M | -$14.6M | $24.1M | -$7.19M | $78.0K | -$28.2M | -$10.1M |
| Capital expenditures | $2.33M | $3.00M | $2.39M | $3.12M | $7.24M | $5.19M | $4.30M | $3.81M | $2.52M | $4.46M |
| Free cash flow | $42.9M | $52.7M | $38.9M | $34.3M | -$21.8M | $18.9M | -$11.5M | -$3.73M | -$30.7M | -$14.6M |
| Share buybacks | $0.00 | $13.6M | $0.00 | $0.00 | — | — | — | $0.00 | $0.00 | $1.67M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $32.3M | $47.5M | $74.1M | $228M | $54.4M | $48.2M | $28.8M | $44.6M | $76.1M | $55.9M |
| Total assets | $726M | $708M | $705M | $836M | $594M | $561M | $553M | $533M | $318M | $280M |
| Total liabilities | $219M | $193M | $163M | $222M | $139M | $122M | $128M | $154M | $112M | $97.2M |
| Long-term debt | — | $96.3M | $91.6M | $132M | — | — | $25.0M | $49.8M | $0.00 | — |
| Shareholders' equity | $507M | $515M | $543M | $615M | $455M | $439M | $424M | $378M | $206M | $183M |
| Retained earnings | -$16.0M | -$11.0M | $5.13M | $66.5M | -$100M | -$132M | -$158M | -$211M | -$395M | -$429M |
| Shares (wtd avg diluted) | 36.2M | 36.6M | 37.1M | 37.5M | 38.0M | 38.3M | 39.0M | 39.5M | 40.2M | 40.9M |
Every figure is extracted from ANGIODYNAMICS INC’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.